We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA INVESTIGATES ADVERSE EVENTS DURING MAMMOGRAMS
FDA INVESTIGATES ADVERSE EVENTS DURING MAMMOGRAMS
April 30, 2004
Women with breast implants are exposed to a serious risk of implant rupture during the compression phase of mammograms used for breast cancer screening, indicates a new FDA study.